NCT03984565View on ClinicalTrials.gov

PAIN: a Project Assessing the Impact of a Novel Cannabinoid Product

PHASE2RecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

June 27, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Chronic Pain
Interventions
DRUG

Cannabidiol

High-CBD, low-THC sublingual product formulated in palm oil

DRUG

Placebo

Placebo sublingual product formulated in palm oil with supplemental terpenes to match CBD product.

Trial Locations (1)

02478

RECRUITING

McLean Hospital, Belmont

All Listed Sponsors
collaborator

Etheridge Foundation

UNKNOWN

lead

Staci Gruber, Ph.D.

OTHER